These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12584856)

  • 1. [Three dimensional quantitative structure-activity relationship of heterocyclic-compounds with di-tert-bultylphenyl inhibitors].
    Bai AP; Guo ZR; Chu FM
    Yao Xue Xue Bao; 2001 May; 36(5):347-50. PubMed ID: 12584856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CoMFA study of COX-2 inhibitors with receptor based alignment.
    Datar PA; Coutinho EC
    J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
    Puntambekar DS; Giridhar R; Yadav MR
    Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partially unified multiple property recursive partitioning (PUMP-RP) analyses of cyclooxygenase (COX) inhibitors.
    Rao SN; Stockfisch TP
    J Chem Inf Comput Sci; 2003; 43(5):1614-22. PubMed ID: 14502496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR.
    Kotani T; Higashiura K
    J Med Chem; 2004 May; 47(11):2732-42. PubMed ID: 15139751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
    Garg R; Kurup A; Mekapati SB; Hansch C
    Chem Rev; 2003 Mar; 103(3):703-32. PubMed ID: 12630850
    [No Abstract]   [Full Text] [Related]  

  • 9. [Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors].
    Wan SB; Yi X; Guo ZR
    Yao Xue Xue Bao; 2002 Apr; 37(4):257-62. PubMed ID: 12579819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
    Srinath P; Rao PN; Knaus EE; Suresh MR
    Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.
    Mozziconacci JC; Arnoult E; Bernard P; Do QT; Marot C; Morin-Allory L
    J Med Chem; 2005 Feb; 48(4):1055-68. PubMed ID: 15715473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styrylheterocycles as a novel class inhibitor of cyclooxygenase-2-mediated prostaglandin E(2) production.
    Lee SK; Park EJ; Lee E; Min HY; Kim EY; Lee T; Kim S
    Bioorg Med Chem Lett; 2004 May; 14(9):2105-8. PubMed ID: 15080988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR and preliminary evaluation of anti-inflammatory activity of series of N-pyrrolylcarboxylic acids.
    Lessigiarska I; Nankov A; Bocheva A; Pajeva I; Bijev A
    Farmaco; 2005 Mar; 60(3):209-18. PubMed ID: 15784239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
    Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
    Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three dimensional quantitative structure-activity relationship of farnesyl protein transferase inhibitors].
    Wan SB; Yi X; Guo ZR
    Yao Xue Xue Bao; 2001 Jun; 36(6):423-6. PubMed ID: 12585125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
    Hsu N; Cai D; Damodaran K; Gomez RF; Keck JG; Laborde E; Lum RT; Macke TJ; Martin G; Schow SR; Simon RJ; Villar HO; Wick MM; Beroza P
    J Med Chem; 2004 Sep; 47(20):4875-80. PubMed ID: 15369391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
    Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
    Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the novel molecular alignment method using the Hopfield Neural Network to 3D-QSAR.
    Arakawa M; Hasegawa K; Funatsu K
    J Chem Inf Comput Sci; 2003; 43(5):1396-402. PubMed ID: 14502472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
    Santagati A; Granata G; Marrazzo A; Santagati M
    Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.